| MW |
systolic blood pressure |
right nephrectomy (for 84 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
arterial blood pressure trait |
male |
days
| 6 |
undefined |
190.0 |
mmHg |
10.0 |
24.49 |
tail cuff plethysmography |
0.0 |
~5/6 to 7/8 nephrectomy |
84 |
days |
100869 |
2523 |
| MW |
systolic blood pressure |
right nephrectomy (for 84 days) then enalapril (20 mg/kg/d) (for 28 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
arterial blood pressure trait |
male |
days
| 9 |
undefined |
141.3 |
mmHg |
6.4 |
19.2 |
tail cuff plethysmography |
0.0 |
~5/6 to 7/8 nephrectomy |
84 |
days |
100872 |
2523 |
| MW |
systolic blood pressure |
right nephrectomy (for 112 days) then enalapril (20 mg/kg/d) (for 56 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
arterial blood pressure trait |
male |
days
| 9 |
undefined |
140.6 |
mmHg |
5.3 |
15.9 |
tail cuff plethysmography |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
100878 |
2523 |
| MW |
systolic blood pressure |
doxorubicin (2 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
days
| 7 |
undefined |
118.0 |
mmHg |
3.0 |
7.94 |
tail cuff plethysmography |
0.0 |
doxorubicin |
|
days |
101161 |
2581 |
| MW |
systolic blood pressure |
right nephrectomy (for 56 days) then enalapril (20 mg/kg/d) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
arterial blood pressure trait |
male |
days
| 9 |
undefined |
183.8 |
mmHg |
5.1 |
15.3 |
tail cuff plethysmography |
0.0 |
~5/6 to 7/8 nephrectomy |
56 |
days |
100865 |
2523 |
| MW |
systolic blood pressure |
right nephrectomy (for 84 days) then captopril (30 mg/kg/d) (for 28 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
arterial blood pressure trait |
male |
days
| 10 |
undefined |
131.0 |
mmHg |
3.9 |
12.33 |
tail cuff plethysmography |
0.0 |
~5/6 to 7/8 nephrectomy |
84 |
days |
100871 |
2523 |
| MW |
systolic blood pressure |
right nephrectomy (for 84 days) then angiotensin II receptor antagonist (20 mg/l) (for 28 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
arterial blood pressure trait |
male |
days
| 7 |
undefined |
157.1 |
mmHg |
15.3 |
40.48 |
tail cuff plethysmography |
0.0 |
~5/6 to 7/8 nephrectomy |
84 |
days |
100874 |
2523 |
| MW |
systolic blood pressure |
right nephrectomy (for 84 days) then lisinopril (10 mg/kg/d) (for 28 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
arterial blood pressure trait |
male |
days
| 10 |
undefined |
129.4 |
mmHg |
7.9 |
24.98 |
tail cuff plethysmography |
0.0 |
~5/6 to 7/8 nephrectomy |
84 |
days |
100873 |
2523 |
| MW |
systolic blood pressure |
right nephrectomy (for 112 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
arterial blood pressure trait |
male |
days
| 6 |
undefined |
180.8 |
mmHg |
8.5 |
20.82 |
tail cuff plethysmography |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
100876 |
2523 |
| MW |
systolic blood pressure |
right nephrectomy (for 112 days) then angiotensin II receptor antagonist (80 mg/l) (for 56 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
arterial blood pressure trait |
male |
days
| 5 |
undefined |
144.0 |
mmHg |
9.1 |
20.35 |
tail cuff plethysmography |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
100881 |
2523 |
| MW |
systolic blood pressure |
unilateral nephrectomy (for 14 days) then puromycin aminonucleoside (100 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
days
| 6 |
undefined |
122.0 |
mmHg |
4.0 |
9.8 |
tail cuff plethysmography |
0.0 |
unx |
14 |
days |
101158 |
2581 |
| MW |
systolic blood pressure |
unilateral nephrectomy (for 42 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
days
| 6 |
undefined |
125.0 |
mmHg |
4.0 |
9.8 |
tail cuff plethysmography |
0.0 |
unx |
42 |
days |
101162 |
2581 |
| MW |
systolic blood pressure |
unilateral nephrectomy (for 70 days) then vehicle control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
days
| 7 |
undefined |
122.0 |
mmHg |
2.0 |
5.29 |
tail cuff plethysmography |
0.0 |
unx |
70 |
days |
101168 |
2581 |
| MW |
systolic blood pressure |
unilateral nephrectomy (for 14 days) and captopril (500 mg/l) (for 42 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
days
| 5 |
undefined |
95.0 |
mmHg |
2.0 |
4.47 |
tail cuff plethysmography |
0.0 |
unx |
42 |
days |
101164 |
2581 |
| MW |
systolic blood pressure |
right nephrectomy (for 112 days) then captopril (30 mg/kg/d) (for 56 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
arterial blood pressure trait |
male |
days
| 10 |
undefined |
135.0 |
mmHg |
6.4 |
20.24 |
tail cuff plethysmography |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
100877 |
2523 |
| MW |
systolic blood pressure |
right nephrectomy (for 112 days) then lisinopril (10 mg/kg/d) (for 56 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
arterial blood pressure trait |
male |
days
| 10 |
undefined |
135.0 |
mmHg |
4.5 |
14.23 |
tail cuff plethysmography |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
100879 |
2523 |
| MW |
systolic blood pressure |
unilateral nephrectomy (for 14 days) and captopril (500 mg/l) (for 14 days) then puromycin aminonucleoside (100 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
days
| 5 |
undefined |
94.0 |
mmHg |
3.0 |
6.71 |
tail cuff plethysmography |
0.0 |
unx |
14 |
days |
101160 |
2581 |
| MW |
systolic blood pressure |
control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
days
| 18 |
undefined |
119.0 |
mmHg |
5.0 |
21.21 |
tail cuff plethysmography |
0.0 |
control |
29 |
days |
101171 |
2581 |
| MW |
systolic blood pressure |
unilateral nephrectomy (for 70 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
days
| 6 |
undefined |
122.0 |
mmHg |
3.0 |
7.35 |
tail cuff plethysmography |
0.0 |
unx |
70 |
days |
101167 |
2581 |
| MW |
systolic blood pressure |
right nephrectomy (for 56 days) then angiotensin II receptor antagonist (20 mg/l) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
arterial blood pressure trait |
male |
days
| 7 |
undefined |
204.3 |
mmHg |
9.7 |
25.66 |
tail cuff plethysmography |
0.0 |
~5/6 to 7/8 nephrectomy |
56 |
days |
100867 |
2523 |
| MW |
systolic blood pressure |
right nephrectomy (for 56 days) then angiotensin II receptor antagonist (80 mg/l) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
arterial blood pressure trait |
male |
days
| 5 |
undefined |
207.0 |
mmHg |
17.7 |
39.58 |
tail cuff plethysmography |
0.0 |
~5/6 to 7/8 nephrectomy |
56 |
days |
100868 |
2523 |
| MW |
systolic blood pressure |
right nephrectomy (for 84 days) then angiotensin II receptor antagonist (80 mg/l) (for 28 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
arterial blood pressure trait |
male |
days
| 5 |
undefined |
150.0 |
mmHg |
9.4 |
21.02 |
tail cuff plethysmography |
0.0 |
~5/6 to 7/8 nephrectomy |
84 |
days |
100875 |
2523 |
| MW |
systolic blood pressure |
right nephrectomy (for 112 days) then angiotensin II receptor antagonist (20 mg/l) (for 56 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
arterial blood pressure trait |
male |
days
| 7 |
undefined |
148.6 |
mmHg |
13.5 |
35.72 |
tail cuff plethysmography |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
100882 |
2523 |
| MW |
systolic blood pressure |
unilateral nephrectomy (for 14 days) then vehicle control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
days
| 7 |
undefined |
118.0 |
mmHg |
2.0 |
5.29 |
tail cuff plethysmography |
0.0 |
unx |
14 |
days |
101159 |
2581 |
| MW |
systolic blood pressure |
unilateral nephrectomy (for 14 days) then vehicle control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
days
| 7 |
undefined |
118.0 |
mmHg |
2.0 |
5.29 |
tail cuff plethysmography |
0.0 |
unx |
42 |
days |
101163 |
2581 |
| MW |
systolic blood pressure |
right nephrectomy (for 56 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
arterial blood pressure trait |
male |
days
| 6 |
undefined |
182.5 |
mmHg |
6.6 |
16.17 |
tail cuff plethysmography |
0.0 |
~5/6 to 7/8 nephrectomy |
56 |
days |
100862 |
2523 |
| MW |
systolic blood pressure |
right nephrectomy (for 56 days) then captopril (30 mg/kg/d) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
arterial blood pressure trait |
male |
days
| 10 |
undefined |
177.0 |
mmHg |
5.0 |
15.81 |
tail cuff plethysmography |
0.0 |
~5/6 to 7/8 nephrectomy |
56 |
days |
100864 |
2523 |
| MW |
systolic blood pressure |
right nephrectomy (for 84 days) then reserpine (5 mg/l) (for 28 days) and hydralazine (80 mg/l) (for 28 days) and controlled hydralazine content drinking water (25 mg/l) (for 28 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
arterial blood pressure trait |
male |
days
| 10 |
undefined |
131.1 |
mmHg |
4.0 |
12.65 |
tail cuff plethysmography |
0.0 |
~5/6 to 7/8 nephrectomy |
84 |
days |
100870 |
2523 |
| MW |
systolic blood pressure |
right nephrectomy (for 112 days) then reserpine (5 mg/l) (for 56 days) and hydralazine (80 mg/l) (for 56 days) and controlled hydralazine content drinking water (25 mg/l) (for 56 days) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
arterial blood pressure trait |
male |
days
| 10 |
undefined |
149.4 |
mmHg |
8.3 |
26.25 |
tail cuff plethysmography |
0.0 |
~5/6 to 7/8 nephrectomy |
112 |
days |
100880 |
2523 |
| MW |
systolic blood pressure |
doxorubicin (2 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
days
| 7 |
undefined |
127.0 |
mmHg |
7.0 |
18.52 |
tail cuff plethysmography |
0.0 |
doxorubicin |
17 |
days |
101165 |
2581 |
| MW |
systolic blood pressure |
doxorubicin (2 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
days
| 7 |
undefined |
137.0 |
mmHg |
4.0 |
10.58 |
tail cuff plethysmography |
0.0 |
doxorubicin |
29 |
days |
101170 |
2581 |
| MW |
systolic blood pressure |
control condition |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
days
| 18 |
undefined |
120.0 |
mmHg |
4.0 |
16.97 |
tail cuff plethysmography |
0.0 |
control |
17 |
days |
101166 |
2581 |
| MW |
systolic blood pressure |
unilateral nephrectomy (for 70 days) and captopril (500 mg/l) (for 70 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
arterial blood pressure trait |
male |
days
| 5 |
undefined |
100.0 |
mmHg |
4.0 |
8.94 |
tail cuff plethysmography |
0.0 |
unx |
70 |
days |
101169 |
2581 |
| MW |
systolic blood pressure |
right nephrectomy (for 56 days) then reserpine (5 mg/l) and hydralazine (80 mg/l) and controlled hydralazine content drinking water (25 mg/l) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
arterial blood pressure trait |
male |
days
| 10 |
undefined |
180.6 |
mmHg |
7.7 |
24.35 |
tail cuff plethysmography |
0.0 |
~5/6 to 7/8 nephrectomy |
56 |
days |
100863 |
2523 |
| MW |
systolic blood pressure |
right nephrectomy (for 56 days) then lisinopril (10 mg/kg/d) |
Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. |
arterial blood pressure trait |
male |
days
| 10 |
undefined |
189.5 |
mmHg |
7.0 |
22.14 |
tail cuff plethysmography |
0.0 |
~5/6 to 7/8 nephrectomy |
56 |
days |
100866 |
2523 |